C. Roy

Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma.

P. Sterk, A. Cohen, J. Burggraaf, 2007, American journal of respiratory and critical care medicine.

Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans.

J. V. van Gerven, G. Ferron, L. Zuurman, 2013, British journal of clinical pharmacology.

Effect of intrapulmonary tetrahydrocannabinol administration in humans

A F Cohen, R. Verpoorte, R. Schoemaker, 2008, Journal of psychopharmacology.

AN IN VIVO POSITRON EMISSION TOMOGRAPHY STUDY OF THE CB1 OCCUPANCY BY AVE1625 USING [C-11]-JHU75528 IN HEALTHY SUBJECTS AND IN PATIENTS WITH SCHIZOPHRENIA.

James Robert Brašić, D. Wong, P. Deutsch, 2010 .

Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR

Dean F. Wong, Arman Rahmim, Hiroto Kuwabara, 2010, NeuroImage.

Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625

R. Schoemaker, L. Zuurman, L. Zuurman, 2010, Journal of psychopharmacology.

Modelling of the concentration—effect relationship of THC on central nervous system parameters and heart rate — insight into its mechanisms of action and a tool for clinical research and development of cannabinoids

R. Schoemaker, L. Zuurman, A. Strougo, 2008, Journal of psychopharmacology.

Changes of the Retinal Nerve Fiber Layer in Patients with Mild Cognitive Impairment and Alzheimer's Disease

Raghupathy, C. Roy, Vishali Kandasamy, 2021 .